alexa Progesterone In The Treatment Of Ischemic Stroke | 22074
ISSN: 2161-1017

Endocrinology & Metabolic Syndrome
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Endocrinology

Fahim Atif
ScientificTracks Abstracts: Endocrinol Metab Synd
DOI: 10.4172/2161-1017.S1.005
Abstract
Transient ischemia accounts for 87% of all strokes. Tissue plasminogen activator is the only FDA-approved drug to treat stroke, but it can be used in at most 5% of stroke patients. This is in part because of its limited 3-4.5-hour time window for treatment, after which its efficacy falls rapidly and in part to its increased risk of blood thinning and bleeding leading to intracranial hemorrhage. There is still no clinically safe and effective neuroprotective treatment that can be given to the remaining 95% of stroke patients. According to the Stroke Therapy Academic Industry Roundtable (STAIR) recommendations, preclinical testing for stroke pharmacotherapies should determine dose?response relationships, extend therapeutic time windows, and test efficacy in multiple stroke models including permanent and transient ischemia, aged animals, and animals with comorbidities. In accordance with the guidelines, we addressed a number of these parameters in our studies using hormone progesterone (PROG). We optimized the most neuroprotective dose of PROG and evaluated optimal therapeutic time window for PROG?s neuroprotective effects following ischemic stroke in older rats. We also examined the beneficial effects of PROG treatment in post-stroke infection-induced functional deficits in older rats. Our data strongly suggest that PROG treatment, at a dose of 8 mg/kg, delayed up to 6 hours can improve functional deficits and reduce brain infarction. Our findings indicate that post-stroke infection worsens stroke outcomes and PROG treatment showed beneficial effects. In conclusion, PROG is neuroprotective, has a wide therapeutic window and is beneficial in treating ischemic stroke under co-morbid conditions.
Biography
Fahim Atif completed his PhD at the age of 26 at Hamdard University, and postdoctoral studies at Emory University School of Medicine in Atlanta. He is an Assistant Professor in Emergency Medicine at Emory University. He has published more than 33 papers in reputed journals and served as an editorial board member and reviewer for a number of peer-reviewed journals. His primary research interests lie in the development of a safe and effective treatment for pediatric and adult ischemic stroke, and for neurogenic tumors (neuroblastoma, glioblastoma, astrocytoma) using the neurosteroid progesterone and its metabolite.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7